Cargando…
Switched alternative splicing events as attractive features in lung squamous cell carcinoma
BACKGROUND: Alternative splicing (AS) plays important roles in transcriptome and proteome diversity. Its dysregulation has a close affiliation with oncogenic processes. This study aimed to evaluate AS-based biomarkers by machine learning algorithms for lung squamous cell carcinoma (LUSC) patients. M...
Autores principales: | He, Boxue, Wei, Cong, Cai, Qidong, Zhang, Pengfei, Shi, Shuai, Peng, Xiong, Zhao, Zhenyu, Yin, Wei, Tu, Guangxu, Peng, Weilin, Tao, Yongguang, Wang, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734344/ https://www.ncbi.nlm.nih.gov/pubmed/34986865 http://dx.doi.org/10.1186/s12935-021-02429-2 |
Ejemplares similares
-
N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non–Small Cell Lung Cancer Prognosis
por: Zhao, Zhenyu, et al.
Publicado: (2021) -
Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma
por: Tu, Guangxu, et al.
Publicado: (2021) -
Whole-genome DNA methylation and DNA methylation-based biomarkers in lung squamous cell carcinoma
por: Cai, Qidong, et al.
Publicado: (2023) -
A Novel Model Based on Genomic Instability-Associated Long Non-Coding RNAs for Predicting Prognosis and Response to Immunotherapy in Patients With Lung Adenocarcinoma
por: Tu, Guangxu, et al.
Publicado: (2021) -
DNA methylome and transcriptome analysis established a model of four differentially methylated positions (DMPs) as a diagnostic marker in esophageal adenocarcinoma early detection
por: Peng, Weilin, et al.
Publicado: (2021)